Outcome of non‐vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation
Author:
Affiliation:
1. Department of CardiologyShanghai Ruijin Hospital, Shanghai Jiao Tong University School of MedicineShanghai China
2. Department of general practiceHudong Community Health Centre, Shanghai University of Traditional Chinese MedicineShanghai China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jce.14365
Reference21 articles.
1. Left atrial appendage: structure, function, and role in thromboembolism
2. Incidence and predictors of left atrial thrombus in patients with atrial fibrillation prior to ablation in the real world of China
3. Non‐vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter
4. Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation
5. Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Current Status of Left Atrial Appendage Thrombus with Atrial Fibrillation;Cardiology Discovery;2023-07-10
2. Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk;Thrombosis Journal;2023-03-30
3. The Safety and Efficacy of Standard-Dose versus Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Left Atrial Appendage Thrombus;Journal of Healthcare Engineering;2021-12-15
4. Diagnosis and Treatment of Intracardiac Thrombus;Journal of Cardiovascular Pharmacology;2021-09
5. Cardiomyopathy and multiple arterial thrombosis in a patient with severe tachyform atrial fibrillation after COVID-19;Aterotromboz = Atherothrombosis;2021-07-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3